Your browser doesn't support javascript.
Scalable biomimetic SARS-CoV­2 nanovaccines with robust protective immune responses.
Chen, Xuenian; Shi, Tongfei; Yang, Chao; Chen, Fangman; He, Xuan; Zhang, Kunbao; Hu, Hanze; Cai, Lulu; Leong, Kam W; Shao, Dan.
  • Chen X; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 511442, China.
  • Shi T; Institutes of Life Sciences, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510006, China.
  • Yang C; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.
  • Chen F; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 511442, China.
  • He X; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China.
  • Zhang K; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 511442, China. chaoyang@scut.edu.cn.
  • Hu H; National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, Guangdong, 510006, China. chaoyang@scut.edu.cn.
  • Cai L; Department of Biomedical Engineering, Columbia University, New York, NY, 10027, USA. chaoyang@scut.edu.cn.
  • Leong KW; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 511442, China.
  • Shao D; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 511442, China.
Signal Transduct Target Ther ; 7(1): 96, 2022 03 25.
Article in English | MEDLINE | ID: covidwho-1758180

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-00942-Y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-00942-Y